chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She developed bruising and a hard lump at the injection site; She developed bruising and a hard lump at the injection site; This is a spontaneous case from initially reported by pharmacist to agency (reference number: SEQ19-06164) on 05-Nov-2019, concerning 42-year-old female patient.  The patient's medical history was not provided.  The patient's concomitant medications were not reported.    On 24-Oct-2019, the patient was administered Flucelvax QIV [influenza vaccine, subunit influenza virus vaccine polyvalent; dose: 0.5 ml, route of administration: intramuscular; anatomical location: right deltoid, batch number: 261727; expiration date: 30-Jun-2019] for influenza prophylaxis.   On an unknown date in 2019, after vaccination, the patient developed bruising and a hard lump at injection site. Pharmacist advised her to come in for him to see the site.   On an unknown date in 2019, the outcome of event was resolved on its own.   This case was assessed as non-serious and causality was not provided.  Follow up received from pharmacist on 17-Dec-2019: The outcome of events updated, stop dates added. Narrative amended accordingly.   Company comment: The patient experienced vaccination site mass and vaccination site bruising after vaccination with the suspect product Flucelvax QIV. Chronology is plausible. No medical history, diagnostic findings and concomitant medications were reported. Considering all the above mentioned, causality between suspect product and the events is assessed as possibly related.; Sender's Comments: The patient experienced vaccination site mass and vaccination site bruising after vaccination with the suspect product Flucelvax QIV. Chronology is plausible. No medical history, diagnostic findings and concomitant medications were reported. Considering all the above mentioned, causality between suspect product and the events is assessed as possibly related.
School nurse called 2 days after shots given to report father taking child to doctor due to covered with hives.  Hives first noticed the day after the vaccines were given.  Unable to contact father by phone due to incorrect number on our records.
pt came in 6 days p/vax w/entire upper arm red, hot & swollen;pt said very itchy;area were shot given beginning to clear up;about size of fifty cent piece not as red as rest of arm;
Information has been received from a registered nurse and a physician concerning an  84 year old female patient with seizure disorder who on 11/4/04 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot # 649732/0513P). On 11/5/04, the patient was seen by the doctor for a severe injection site reaction. Her reaction was described by the doctor as being a very diffuse, warm, erythematous, swollen rash around injection site about 4-5 inches up and down the arm. The patient was treated with cephalexin initial because the reaction was thought to be bacterial, but the physician confirmed that it was not. It was reported that the patient was found unresponsive on an unspecified date at home and was brought to the hospital by ambulance. She was hospitalized for 3-4 days and was administered anticonvulsant medication. The physician reported that the patient was not hospitalized due to the vaccination. The physician expressed concern regarding the lot. Additional information has been requested. It was reported that the patient's husband had a similar experience (WAES0411USA01765).
Approximately 24 hours after the vaccine administration, individual reported an enlarged and painful lymph node in the left axilliary space.  Individual stated they took Tylenol which seemed to help and symptoms began to resolve around 8:30 pm on 9/28/2021.
Patient experienced body aches and "flu-like" symptoms for approximately 24 hours requiring her to rest in bed.
I had stuffy head like if I was getting a cold, On Dec 30, 2022, I took a home test for COVID-19 and it was positive. I called my doctor and prescribed PAXLOVID. I took PAXLOVID for 5 days and isolated. I did not get any other symptoms.
Information has been received from a medical assistant concerning a 59 year old female diabetic who on 10/11/2006 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot 651319/1007P). Concomitant therapy included influenza virus vaccine administered at the same visit in separate arms (separate sites). On approximately 10/11/06 the pt developed a reaction in arm where the Pneumococcal 23v polysaccharide vaccine was administered, that ranged from redness to blotchiness to pain. Medical attention was sought. it was also reported that the pt had a problem with her blood sugar that was described as she went into diabetic coma but came right out. The pt did not visit the hospital. At the time of the report she was still experiencing symptoms. The medical assistant requested a lot check. No product quality complaint was involved. Upon internal review, diabetic coma was considered to be an other important medical event (OMIC). Additional information has been requested.
had 1 episode of shortness of breath; tachycardia; dizziness / light headedness; This is a spontaneous report from a contactable consumer reporting for herself. This 29-year-old female patient (non-pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 at 15:30, at single dose, for COVID-19 immunization. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history was not reported. The patient was not diagnosed with COVID before vaccination. Concomitant medications included vitamin C and sambucus nigra fruit (ELDERBERRY) and unspecified multivitamin and immune support. On 19Dec2020 at 23:30 the patient experienced one episode of shortness of breath, tachycardia, dizziness. Lasted for about 20 minutes and totally resolved within 1.5 hours. Continuing to have light headedness 24 hours after. Emergency room/department or urgent care required. No treatment was given. COVID was tested post vaccination on 20Dec2020 via nasal swab (rapid test), with negative result. The events were resolving.  Information on the lot/batch number has been requested.
Menstrual cycle started 11 days early, flow was light compared to normal cycle but lasted longer than usual
Swollen lymph nodes; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 31Mar2021 at 10:45 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not received any other medications with in 2 weeks of COVID-19 vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 10Mar2021 at 11:30 as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks, prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The patient experienced swollen lymph nodes on 01Apr2021 at 17:00 . The patient did not receive any treatment for the reported event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph nodes was recovering.   No follow-up attempts are needed. No further information is expected.